DrugPatentWatch Database Preview
Drugs in Development Information for Telotristat ethyl
» See Plans and Pricing
What is the drug development status for Telotristat ethyl?
Telotristat ethyl is an investigational drug.
There have been 12 clinical trials for Telotristat ethyl.
The most recent clinical trial was a Phase 1 trial, which was initiated on April 1st 2020.
The most common disease conditions in clinical trials are Neuroendocrine Tumors, Carcinoid Tumor, and Malignant Carcinoid Syndrome. The leading clinical trial sponsors are Lexicon Pharmaceuticals, Ipsen, and Emory University.
There are twelve US patents protecting this investigational drug and one hundred and eleven international patents.
Summary for Telotristat ethyl
| US Patents | 12 |
| International Patents | 111 |
| US Patent Applications | 28 |
| WIPO Patent Applications | 43 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2020-04-01) |
| Vendors | 36 |
Recent Clinical Trials for Telotristat ethyl
| Title | Sponsor | Phase |
|---|---|---|
| Telotristat Ethyl for Reducing Intraoperative Carcinoid Crisis in Patients With Neuroendocrine Tumors | University of Chicago | Phase 2 |
| Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer | Lexicon Pharmaceuticals | Phase 2 |
| Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer | Emory University | Phase 2 |
Clinical Trial Summary for Telotristat ethyl
Top disease conditions for Telotristat ethyl
Top clinical trial sponsors for Telotristat ethyl
US Patents for Telotristat ethyl
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Telotristat ethyl | Start Trial | Tricyclic imidazole compounds as inhibitors of tryptophan hydroxylase | ACTELION PHARMACEUTICALS LTD (Allschwil, CH) | Start Trial |
| Telotristat ethyl | Start Trial | 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use | Lexicon Pharmaceuticals, Inc. (The Woodlands, TX) | Start Trial |
| Telotristat ethyl | Start Trial | 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use | Lexicon Pharmaceuticals, Inc. (The Woodlands, TX) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Telotristat ethyl
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Telotristat ethyl | Canada | CA2927121 | 2033-11-19 | Start Trial |
| Telotristat ethyl | China | CN105745211 | 2033-11-19 | Start Trial |
| Telotristat ethyl | European Patent Office | EP3071567 | 2033-11-19 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
